Lee, J.-H.; Choi, N.; Kim, S.; Jin, M.S.; Shen, H.; Kim, Y.-C.
Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells. Pharmaceuticals 2022, 15, 440.
https://doi.org/10.3390/ph15040440
AMA Style
Lee J-H, Choi N, Kim S, Jin MS, Shen H, Kim Y-C.
Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells. Pharmaceuticals. 2022; 15(4):440.
https://doi.org/10.3390/ph15040440
Chicago/Turabian Style
Lee, Je-Heon, Namjeong Choi, Subin Kim, Mi Sun Jin, Haihong Shen, and Yong-Chul Kim.
2022. "Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells" Pharmaceuticals 15, no. 4: 440.
https://doi.org/10.3390/ph15040440
APA Style
Lee, J.-H., Choi, N., Kim, S., Jin, M. S., Shen, H., & Kim, Y.-C.
(2022). Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells. Pharmaceuticals, 15(4), 440.
https://doi.org/10.3390/ph15040440